| Mrs Michelle Lee Hagen, ACNP-BC | |
|
1710 Harrison St, Batesville, AR 72501-7303 | |
| (870) 262-1200 | |
| (870) 262-6199 |
| Full Name | Mrs Michelle Lee Hagen |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Acute Care |
| Location | 1710 Harrison St, Batesville, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063710564 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | A03503 ANP (Arkansas) | Primary |
| Entity Name | White River Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410229 PECOS PAC ID: 0143134270 Enrollment ID: O20031203000615 |
News Archive
Employment for frontline healthcare workers should be conditional on COVID-19 vaccination, and unless they have a valid medical reason for not getting the jab, persistent refusniks should be temporarily redeployed to protect their colleagues and patients, argue ethicists in the Journal of Medical Ethics.
Prozac, the trade name for the drug fluoxetine, was introduced to the U.S. market for the treatment of depression in 1988.
The Economist profiles Plasmodium vivax, a type of malaria that affects between 80 million to 390 million people worldwide annually with a cost to sufferers between $1.4 billion and $4 billion each year.
Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) announced today that an independent data monitoring committee (IDMC) has recommended the early termination of its Phase 3, 52-week, placebo-controlled, intramuscular depot aripiprazole trial.
› Verified 1 days ago
| Entity Name | White River Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235101601 PECOS PAC ID: 0143134270 Enrollment ID: O20031204000986 |
News Archive
Employment for frontline healthcare workers should be conditional on COVID-19 vaccination, and unless they have a valid medical reason for not getting the jab, persistent refusniks should be temporarily redeployed to protect their colleagues and patients, argue ethicists in the Journal of Medical Ethics.
Prozac, the trade name for the drug fluoxetine, was introduced to the U.S. market for the treatment of depression in 1988.
The Economist profiles Plasmodium vivax, a type of malaria that affects between 80 million to 390 million people worldwide annually with a cost to sufferers between $1.4 billion and $4 billion each year.
Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) announced today that an independent data monitoring committee (IDMC) has recommended the early termination of its Phase 3, 52-week, placebo-controlled, intramuscular depot aripiprazole trial.
› Verified 1 days ago
| Entity Name | White River Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578872297 PECOS PAC ID: 0143134270 Enrollment ID: O20110111000718 |
News Archive
Employment for frontline healthcare workers should be conditional on COVID-19 vaccination, and unless they have a valid medical reason for not getting the jab, persistent refusniks should be temporarily redeployed to protect their colleagues and patients, argue ethicists in the Journal of Medical Ethics.
Prozac, the trade name for the drug fluoxetine, was introduced to the U.S. market for the treatment of depression in 1988.
The Economist profiles Plasmodium vivax, a type of malaria that affects between 80 million to 390 million people worldwide annually with a cost to sufferers between $1.4 billion and $4 billion each year.
Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) announced today that an independent data monitoring committee (IDMC) has recommended the early termination of its Phase 3, 52-week, placebo-controlled, intramuscular depot aripiprazole trial.
› Verified 1 days ago
| Entity Name | White River Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831495423 PECOS PAC ID: 0143134270 Enrollment ID: O20110426000404 |
News Archive
Employment for frontline healthcare workers should be conditional on COVID-19 vaccination, and unless they have a valid medical reason for not getting the jab, persistent refusniks should be temporarily redeployed to protect their colleagues and patients, argue ethicists in the Journal of Medical Ethics.
Prozac, the trade name for the drug fluoxetine, was introduced to the U.S. market for the treatment of depression in 1988.
The Economist profiles Plasmodium vivax, a type of malaria that affects between 80 million to 390 million people worldwide annually with a cost to sufferers between $1.4 billion and $4 billion each year.
Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) announced today that an independent data monitoring committee (IDMC) has recommended the early termination of its Phase 3, 52-week, placebo-controlled, intramuscular depot aripiprazole trial.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Michelle Lee Hagen, ACNP-BC 1710 Harrison St, Batesville, AR 72501-7303 Ph: (870) 262-1200 | Mrs Michelle Lee Hagen, ACNP-BC 1710 Harrison St, Batesville, AR 72501-7303 Ph: (870) 262-1200 |
News Archive
Employment for frontline healthcare workers should be conditional on COVID-19 vaccination, and unless they have a valid medical reason for not getting the jab, persistent refusniks should be temporarily redeployed to protect their colleagues and patients, argue ethicists in the Journal of Medical Ethics.
Prozac, the trade name for the drug fluoxetine, was introduced to the U.S. market for the treatment of depression in 1988.
The Economist profiles Plasmodium vivax, a type of malaria that affects between 80 million to 390 million people worldwide annually with a cost to sufferers between $1.4 billion and $4 billion each year.
Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) announced today that an independent data monitoring committee (IDMC) has recommended the early termination of its Phase 3, 52-week, placebo-controlled, intramuscular depot aripiprazole trial.
› Verified 1 days ago
Mr. Leroy Maupin Jr., APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 407 Virginia Dr, Batesville, AR 72501 Phone: 870-793-4200 Fax: 870-698-1353 | |
Angela Burleson, MS, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1215 Sidney St Ste 202, Batesville, AR 72501 Phone: 870-262-2000 | |
Rachel Jeannette Johnson, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 905 20th St Ste B, Batesville, AR 72501 Phone: 870-569-4942 Fax: 870-569-4943 | |
Cynthia Elaine Jackson, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3443 Harrison St, Batesville, AR 72501 Phone: 870-698-1635 Fax: 870-612-3389 | |
Brandy M Moore, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 255 Virginia Dr, Batesville, AR 72501 Phone: 870-793-4300 | |
Robin Kerr, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1215 Sidney St Ste 300, Batesville, AR 72501 Phone: 870-793-1126 Fax: 870-793-1180 |